|
A View of the Biochemistry Laboratory - Marker Gene Technologies, Inc
OUR SENIOR STAFF
Dr. John Naleway
President, CEO of MGTI -- Ph.D. Biochemistry, Adjunct faculty member in the
Departments of Chemistry and Molecular Biology at the University of Oregon.
Timothy L. McCutcheon
Legal Counsel -- MS Biology, J.D., University of Oregon, corporate and patent
attorney with extensive science background.
Michael P. Coughlin
Director of Business Development. MBA University of Oregon Business School, Sr.
Partner in AmEuro, LLC and former CEO of Percon, Inc.
Dr. Anthony P.
Guzikowski
Chemistry Director -- Adjunct Faculty member in the Department of Chemistry
at the University of Oregon.
Daniel J. Coleman
B.S. in Biology from the University of Oregon,
Enzymatic assays, metabolism, stability and distribution assay
development.
Marker Gene Technologies, Inc. was
founded in 1993 at the University of Oregon Riverfront Research Park to
develop new products for the biotechnology and medical industries. The
company has received a number of competitive grant awards for its work in
cancer research and therapeutics from the National Institutes of Health as
well as funding from the National Science Foundation for new uses of Marker
Genes for agricultural biotechnology, cell culturing, bacteriology and basic research
applications. Contact us for more information about our work in these areas.
The company has a staff of
highly trained professionals with expertise in the areas of carbohydrate
chemistry and biology; organic synthesis; fluorescence chemistry; molecular
biology; DNA sequencing; subcloning; Northern blotting; Western blotting;
cell culture; gel electrophoresis of DNA, RNA, and proteins; cell viability
assays; bacterial detection; and related areas.
|
